EP2970980
Framleiðsluaðferðir til að stjórna innihaldi C-enda lýsíns, galaktósa og síalsýru í raðbrigða prótínum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.3.2014EP published:
15.8.2018EP application number:
14768761.0
EP translation filed:
19.9.2018Grant published:
15.10.2018EPO information:
European Patent Register
Max expiry date:
6.3.2034Expiry date:
6.3.2023
Title:
MANUFACTURING METHODS TO CONTROL C-TERMINAL LYSINE, GALACTOSE AND SIALIC ACID CONTENT IN RECOMBINANT PROTEINS
Timeline
Today
7.3.2014EP application
15.8.2018EP Publication
19.9.2018Translation submitted
15.10.2018Registration published
6.3.2023Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, 19044, Horsham, PA, US
Name:
Janssen Biologics B.V.Address:
Einsteinweg 101, 2333, Leiden, NL
Inventor
Name:
FLIKWEERT, MarcelAddress:
NL-2333 CB Leiden, NL
Name:
GOOCHEE, CharlesAddress:
Malvern, Pennsylvania, US
Name:
MASLANKA, FrancisAddress:
Malvern, Pennsylvania, US
Name:
NAGEL, Francisus Johannes IgnatiusAddress:
NL-2333 CB Leiden, NL
Name:
RYLAND, JamesAddress:
Malvern, Pennsylvania, US
Name:
SCHAFER, EugeneAddress:
Malvern, Pennsylvania, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361791094 PDate:
15.3.2013Country:
US
Classification
Categories:
C12N 15/13, C07K 16/00, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 7.2.2019
Expires: 6.3.2020
Payer: Árnason Faktor
Number: 7
Paid: 18.2.2020
Expires: 6.3.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2021
Expires: 6.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.2.2022
Expires: 6.3.2023
Payer: Árnason Faktor ehf.